STARTUP PROFILE

Mon4t

COUNTRY
Israel
FOUNDED
2017
CATEGORY
Diagnostics and Assessment
Transforming standard smartphones into AI-powered neurological test devices for remote motor, cognitive, and affective monitoring.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Unknown
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Parkinson's
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
Mon4t turns commodity smartphones into neurological assessment devices, making it a software-first digital biomarker platform for remote monitoring of motor and cognitive status. Its strongest advantage is accessibility and low deployment friction, though this also lowers barriers to imitation.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Mon4t